Cetus/NNP Corp./NNP said/VBD 0/-NONE- the/DT government/NN of/IN Spain/NNP approved/VBD the/DT marketing/NN of/IN its/PRP$ Proleukin/NNP interleukin-2/NN drug/NN 0/-NONE- *T*-1/-NONE- to/TO treat/VB kidney/NN cancer/NN ./.
The/DT biotechnology/NN concern/NN said/VBD 0/-NONE- Spanish/JJ authorities/NNS must/MD still/RB clear/VB the/DT price/NN for/IN the/DT treatment/NN ,/, but/CC that/IN it/PRP expects/VBZ *-1/-NONE- to/TO receive/VB such/JJ approval/NN by/IN year/NN end/NN ./.
Four/CD other/JJ countries/NNS in/IN Europe/NNP have/VBP approved/VBN Proleukin/NNP in/IN recent/JJ months/NNS ./.
Cetus/NNP is/VBZ currently/RB trying/VBG *-1/-NONE- to/TO obtain/VB federal/JJ regulatory/JJ clearance/NN for/IN U.S./NNP distribution/NN ./.

